Ads
related to: Sars-cov-2 Antibody- Sigma® Life Science
Find cell culture, antibodies and
thousands of biological products
- Classic Lab Chemicals
High-quality laboratory reagents.
Solvents, salts, acids, bases
- Analytical/Chromatography
Browse our Analytical Reagents,
Standards, Microbiology and more.
- Order Center
Build a Shopping Cart, View Orders
Access ordering instructions
- Sign In
Sigma® Life Science
View contract pricing, get quotes
- Register an Account
Get product updates, special offers
Save favorites & shopping lists
- Sigma® Life Science
Search results
Common antibiotic may be helpful in fighting respiratory viral infections
Medical Xpress· 6 days agoA team led by Yale's Akiko Iwasaki and former Yale researcher Charles Dela Cruz successfully tested the effectiveness of neomycin, a common antibiotic, to prevent or treat respiratory viral ...
EXCLUSIVE: Virax Biolabs Launches Immune Profiling Solutions To Evaluate Adaptive Immunity In...
Benzinga via Yahoo Finance· 4 days agoThursday, Virax Biolabs Group Limited (NASDAQ: VRAX) announced it is launching ‘ImmuneSelect' within...
Common Antibiotic Shows Promise in the Treatment of Respiratory Viral Infections
Technology Networks· 6 days agoA new, Yale-led study suggests that a range of respiratory viral infections — including COVID-19 and...
Immunologist receives biomedical research award | Cornell Chronicle
Cornell News Service· 4 days agoAshley Nelson, assistant professor of immunology research in the Department of Pediatrics at Weill...
EXCLUSIVE: Virax Biolabs Launches Immune Profiling Solutions To Evaluate Adaptive Immunity In...
Investing.com· 4 days agoEXCLUSIVE: Virax Biolabs Launches Immune Profiling Solutions To Evaluate Adaptive Immunity In...
EXCLUSIVE: Virax Biolabs Launches Immune Profiling Solutions To Evaluate Adaptive Immunity In...
Benzinga· 4 days agoThursday, Virax Biolabs Group Limited (NASDAQ: VRAX) announced it is launching ‘ImmuneSelect' within the ViraxImmune T-Cell diagnostic platform for research-use-only (RUO) at the European Society ...
Big Pharma's Blockbuster Creation Continues to Disappoint
Mercola· 5 days agoMessenger ribonucleic acid (mRNA) vaccines are being described as a "new era in vaccinology."1 Research is underway to develop mRNA shots for not only coronaviruses but also C. difficile, hepatitis ...
Less than half of nursing home residents are up to date with their COVID-19 vaccines, study finds:...
Yahoo Life Style via AOL· 7 days agoHere’s your go-to guide with everything you need to know about COVID-19, including testing expanding...
Significant global variation in COVID-19 guidelines: Most countries recommend at least one treatment...
Medical Xpress· 6 days agoNational clinical guidelines for the treatment of COVID-19 vary significantly around the world, with...
Vilya Announces New Publication in Science Validating Foundational Approach to Design of Novel...
Morningstar· 4 days agoVILYA, Inc. (Vilya), a biotechnology company creating a new class of medicines that precisely targets disease biology, today announced the publication of a new study in Science that validates ...
